What is the management of a short PR interval in a 35-year-old asymptomatic man?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

A short PR interval in an asymptomatic 35-year-old man likely represents Wolff-Parkinson-White (WPW) pattern, which requires no specific treatment if truly asymptomatic, but the patient should be referred to a cardiologist for confirmation with a 12-lead ECG and risk stratification, as recommended by the 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia 1. The patient should be educated about potential symptoms to watch for, including palpitations, dizziness, syncope, or chest pain, which would warrant immediate medical attention.

  • Regular follow-up every 1-2 years is recommended to monitor for symptom development.
  • The patient should avoid medications that enhance AV nodal conduction like digoxin, verapamil, and diltiazem if arrhythmias develop.
  • The short PR interval occurs because electrical impulses bypass the normal conduction pathway through an accessory pathway (Bundle of Kent), connecting the atria directly to the ventricles.
  • This creates a potential circuit for reentrant tachycardias, though many individuals with this ECG finding remain asymptomatic throughout life.
  • If symptoms develop, treatment options include antiarrhythmic medications like flecainide or propafenone, or catheter ablation of the accessory pathway, which is curative in over 95% of cases.
  • According to the European Heart Journal, a short PR interval without delta wave has been reported as a normal variant of athlete’s ECG, but it needs a careful evaluation because it may reflect either a ventricular pre-excitation syndrome or an underlying structural heart disease 1.
  • The 2015 ACC/AHA/HRS guideline also recommends that an EP study is reasonable in asymptomatic patients with pre-excitation to risk-stratify for arrhythmic events, and catheter ablation of the accessory pathway is reasonable in asymptomatic patients with pre-excitation if an EP study identifies a high risk of arrhythmic events 1.

From the Research

Management of Short PR Interval in a 35-year-old Man with No Symptoms

  • The patient's condition suggests Wolff-Parkinson-White (WPW) syndrome, which is characterized by a short PR interval and the presence of an accessory electrical pathway in the heart 2.
  • The management of WPW syndrome typically involves catheter ablation to eliminate the accessory pathway, which can help prevent the development of atrial fibrillation (AF) and other arrhythmias 3, 4.
  • However, the decision to proceed with catheter ablation in an asymptomatic patient should be made on a case-by-case basis, taking into account the patient's individual risk factors and the potential benefits and risks of the procedure 5, 6.
  • Studies have shown that patients with WPW syndrome who undergo successful catheter ablation have a significant reduction in the incidence of AF and other arrhythmias, and improved symptoms and quality of life 3, 4, 6.
  • Nevertheless, some patients may still experience arrhythmia symptoms after ablation, which can be due to various factors such as recurrence of the accessory pathway, development of new arrhythmias, or other underlying conditions 6.

Risk Factors for Atrial Fibrillation in WPW Syndrome

  • The presence of an accessory pathway with fast anterograde conduction is a significant risk factor for the development of AF in patients with WPW syndrome 2.
  • Other risk factors include older age, male sex, and increased atrial vulnerability, which can be assessed through electrophysiologic studies and atrial endocardial catheter mapping 4, 5.
  • Patients with a history of AF before ablation are more likely to experience recurrent AF after the procedure, highlighting the importance of careful patient selection and risk stratification 4, 6.

Monitoring and Follow-up

  • Regular follow-up and monitoring are essential to detect any potential complications or recurrences after catheter ablation 3, 6.
  • Patients should be educated on the signs and symptoms of arrhythmias and instructed to seek medical attention if they experience any palpitations, shortness of breath, or other concerning symptoms 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Atrial Fibrillation in the Wolff-Parkinson-White Syndrome.

Journal of atrial fibrillation, 2011

Research

Episodes of atrial fibrillation and atrial vulnerability after successful radiofrequency catheter ablation in patients with Wolff-Parkinson-White syndrome.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2002

Research

Mechanisms for atrial fibrillation in patients with Wolff-Parkinson-White syndrome.

Journal of cardiovascular electrophysiology, 2002

Research

Perception and documentation of arrhythmias after successful radiofrequency catheter ablation of accessory pathways.

Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc, 2001

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.